New variant of COVID-19 71% more transmittable, says Hyderabad’s CCMB

The Centre for Cellular and Molecular Biology said that the new variant of COVID-19 is 71 per cent more transmittable than the other variants.

By: Jahnavi Sarma | | Updated: December 30, 2020 8:40 am

First reported in the UK in September, the new variant (B.1.1.7) makes up for 60 per cent of all coronavirus infections in that country.

The new variant of the coronavirus SARS-CoV-2 that causes COVID-19 is believed to be 71 per cent more transmittable than the other variants, the Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) said on Tuesday when India confirmed six cases of the new strain. The leading research institute has underlined the importance to launch an extensive genome surveillance of the virus to assess the extent of the spread of the new virus. “We should also keep an eye on other variants that might emerge independently, as India houses the second largest population infected with this virus, at present,” CCMB Director, Dr Rakesh Mishra said. CSIR-CCMB is one of the 10 research institutes in India that is tracing the new variant in India. Also Read - Obesity, alcohol consumption can lower effectiveness of Covid-19 vaccines

New variant accounts for 60 per cent infections in UK

First reported in the UK in September, the new variant (B.1.1.7) makes up for 60 per cent of all coronavirus infections in that country. Many countries including India have temporarily halted flights from the UK. By tracing and testing 33,000 passengers who have flown into India from the UK, India has confirmed the presence of this new variant in the country. Also Read - Almost 30% of recovered COVID-19 patients develop complications within 5 months, over 12% die

Extensive genome surveillance important

“We have needed to expedite the viral genome sequencing efforts, and check for the presence of the new variant in India. We have used both, the traditional Sanger sequencing method as well as the modern Next-Gen Sequencing tools,” said Dr Divya Tej Sowpati, who leads the coronavirus genome sequencing efforts at CCMB. Also Read - COVID-19 vaccine side effects: Loss of sensation in arms and more reported by Pune health workers

New variant shows 17 mutations

The new variant shows 17 mutations in its genetic material. Of these eight affect its spike protein, which expresses on its outer surface, and binds to the ACE receptors in the host cells. One of the mutations is believed to enhance the binding between the virus and the receptors, thus, facilitating its entry into the host cells. The mutations have, however, not worsened the symptoms or the disease outcomes. They are also not an impediment to the vaccine development. The testing protocol also remains the same. The only problem is that the new variant spreads more easily than the others.

“The measures to avoid infection still remain the same. Using masks when in presence of others, avoiding crowded places, maintaining social distancing are the most effective and feasible ways for avoiding this virus, including the new variant,” Dr Mishra said.

(With inputs from IANS)

Published : December 30, 2020 8:00 am | Updated:December 30, 2020 8:40 am

Read Disclaimer

Genes linked to common brain disorder, Chiari 1 malformation, identified

Winter diet for asthma patients: Know what to eat and what to avoid

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com

+91 – 22 – 6697 1234

91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

We respect your privacy

Genes linked to common brain disorder, Chiari 1 malformation, identified

Winter diet for asthma patients: Know what to eat and what to avoid

Obesity, alcohol consumption can lower effectiveness of Covid-19 vaccines

‘Don’t take Covid-19 vaccine shot if...': Covaxin company warns people amid concerns

Covid-19 vaccine alert: Covishield not advised to those allergic to any of its ingredients

Almost 30% of recovered COVID-19 patients develop complications within 5 months, over 12% die

COVID-19 vaccine side effects: Loss of sensation in arms and more reported by Pune health workers

About The health Site

Useful Links